维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Eaby"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management 显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
2	Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving par- adigm in clinieal management 显示文摘	LYNCH TJ KIM ES EABY B	2007	Oncologist2007，12，5：	1
3	Epidermal growth factor re- ceptor inhibitor-associated cutaneous toxicities: an evolving par- adigm in clinical management 显示文摘	Lynch TJ Kim ESJr Eaby B	2007	Oncologist2007，12，5：	1
4	Epidermal growth factor receptor in- hibitor - associated cutaneous toxicities : an evolving paradigm in chnicaI management 显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
5	Epidermal growth factor receptor inhibitor-associated cuta- neous toxicities: an evolving paradigm in clinical management显示文摘	Lynch T J Kim ES Eaby B	2007	Oncologist2007，12，5：	1
6	Epidermal growth factor receptorinhibitor-associated cutaneous toxicities: an evolving paradigm inclinical management显示文摘	Lynch TJ Kim ES Eaby B	2007	Oncologist2007，12，5：	1
7	An interdisciplinary consensus on managing skin reactions associated with hu- man epidermal growth factor receptor inhibitors 显示文摘	Eaby B Culkin A Lacouture ME	2008	Clin J Oncol Nuts2008，12，2：	1
8	Epidermal growth fac- tor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinicalmanagement 显示文摘	LYNCH TJ JR KIM ES EABY B	2007	Oncologist2007，12，5：	1
9	Epidermal growth factor receptor inhibitor-associated cutaneous toxieities:an evolving paradigm in clinical management显示文摘	Lynch TJ Kim ES Eaby B		0，，05：	1
10	Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
11	Understanding the concept of chemotherapy--related nausea:the patient experi- ence显示文摘	Molassiotis A Stricker CT Eaby B	2008	Eur J Cancer Care2008，17，5：	1
12	Epidermal growth factor receptor inhibiror-associated cutaneous toxicities ; An evolving paradigm inclinical management显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
13	Epidermal growth factor receptor inhibitor-associated cutaneous toxic- ities: an evolving paradigm in clinical management 显示文摘	LYNCH TJ JR KIM ES EABY B	2007	Oncologist2007，12，5：	1
14	Epider mal grow th factor receptor inhibitor-associated cutaneous toxicities:An evolving paradigm in clinical management显示文摘	Lynch TJ Jr Kim ES Eaby B et a1	2007	Oncologist2007，12，5：	1
15	Epidermal growth factorreceptor inhibitor-associated cutaneous toxicities:An evolvingparadigm in clinical management显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
16	Sr isotopic variations along the Juan de Fuca Ridge显示文摘	Eaby J S Clague D A Delaney J R	1984	J Geophys Res1984，89，9：	1
17	EpidermaL growth factor receptor inhibitor-associated cutaneous toxicities:An evoLving paradigm in cLinicaL management显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	OncoLogist2007，12，5：	1
18	Epidermal growth factor recep- tor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management 显示文摘	]Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
19	Epidermal growth factor receptor inhibitor –associated cutaneous toxicities:An evolving paradigm in clinical management显示文摘	Lynch TJ Jr Kim ES Eaby B	2007	Oncologist2007，12，5：	1
20	Understanding the concept of chemotherapy - related nausea: the patient experience 显示文摘	MOLASSIOTIS A STRICKER C T EABY B	2008	Eur J Cancer Care (Engl)2008，17，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示